Tag: FDA

Aseptic Gowning Deviation Investigation Following Maintenance Activities Aseptic conditions are critical in the manufacturing of parenteral dosage forms. Any deviation, especially after maintenance interventions, can lead to significant ramifications, including…

Managing Em Excursion In Grade A Zones Following Maintenance Interventions In pharmaceutical manufacturing, particularly within sterile environments, deviations from established Grade A conditions can pose significant risks to product quality…

Investigating Em Excursion in Grade A Environments During Changeover Campaigns Manufacturing pharmaceuticals in a Grade A environment is critical, particularly for parenteral dosage forms where sterility is paramount. An excursion…

Investigation of Ccit Failure during Hold-Time Study: Ensuring Patient Safety and Compliance A holding time study is critical in pharmaceutical manufacturing, particularly for parenteral dosage forms, as it assesses the…

Understanding and Investigating Particulate Matter OOS During Terminal Sterilization During terminal sterilization of injectable products, the presence of particulate matter can trigger Out of Specification (OOS) results, posing significant compliance…

Addressing Failures in Smoke Studies During Terminal Sterilization: A Comprehensive Investigation Approach In pharmaceutical manufacturing, the reliability of sterilization processes is critical, particularly for parenteral dosage forms. A smoke study…

Assessing Particulate Matter OOS After Sterile Filtration: An Investigation for Safety and Compliance In the pharmaceutical industry, maintaining a sterile environment is paramount, especially when producing injectable products. A situation…

Investigating Filter Integrity Failures in Terminal Sterilization: Assessing Risks in Pharmaceutical Manufacturing In the pharmaceutical manufacturing environment, a filter integrity failure during terminal sterilization can pose significant risks to product…